Canada Life’s Antares Pharma, Inc. ATRS Stock Holding History

Canada Life’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-10,457	Closed	-$45K	–	2495
2022 Q1	$45K	Hold	10,457	–	–	﹤0.01%	2180
2021 Q4	$37K	Hold	10,457	–	–	﹤0.01%	2261
2021 Q3	$38K	Hold	10,457	–	–	﹤0.01%	2304
2021 Q2	$45K	Hold	10,457	–	–	﹤0.01%	2308
2021 Q1	$43K	Hold	10,457	–	–	﹤0.01%	2340
2020 Q4	$42K	Hold	10,457	–	–	﹤0.01%	2348
2020 Q3	$28K	Hold	10,457	–	–	﹤0.01%	2353
2020 Q2	$29K	Hold	10,457	–	–	﹤0.01%	2413
2020 Q1	$25K	Hold	10,457	–	–	﹤0.01%	2335
2019 Q4	$49K	Buy	+10,457	New	+$42.8K	﹤0.01%	2271
2019 Q3	–	Sell	-15,418	Closed	-$50K	–	2526
2019 Q2	$50K	Buy	+15,418	New	+$44.6K	﹤0.01%	2442
2019 Q1	–	Sell	-28,692	Closed	-$75K	–	2720
2018 Q4	$75K	Buy	+28,692	New	+$94.5K	﹤0.01%	2243

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Canada Life's ATRS Position: Q2 2022 in Review

Canada Life sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 10,457 shares — an estimated $45K sold.

Canada Life first reported a position in ATRS in Q4 2018 and held it in 12 quarters. The position peaked at $75K in Q4 2018. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Canada Life reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Canada Life sold 10,457 Antares Pharma, Inc. shares in Q2 2022, an estimated $45K.
Canada Life first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 12 quarters.
Canada Life's Antares Pharma, Inc. position peaked at $75K in Q4 2018.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Canada Life's 13F filing for Q2 2022, filed 9 Aug 2022.